Showing results (11-20 of 82) with videos related to
Sort By:
Pageof 9
Journal of Cancer Research and Clinical Oncology|February 20, 2025
Effect of the COVID-19 pandemic and lockdown on cancer stage distribution and time to treatment initiation using cancer registry data of the Swiss cantons of Zurich and Zug from 2018 to 2021Flurina Suter, Miriam Wanner, Andreas Wicki, et al.Nature Reviews. Cancer|December 9, 2022
Biology, vulnerabilities and clinical applications of circulating tumour cellsAlexander Ring, Bich Doan Nguyen-Sträuli, Andreas Wicki, et al.Cancers|October 16, 2024
Impact of the COVID-19 Pandemic and Lockdown on Cancer Diagnoses Using Swiss Cantonal Cancer Registry DataFlurina Suter, Miriam Wanner, Dominik Menges, et al.Cancer Cell|April 18, 2006
Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeletonAndreas Wicki, François Lehembre, Nikolaus Wick, et al.Frontiers in Oncology|July 3, 2025
Case Report: Metastatic colorectal cancer with ALK-CEP44 fusion and rapid resistance developmentSilvan Hofmann, Claudine Egger, Silke Potthast, et al.International Journal of Pharmaceutics|February 22, 2015
Large-scale manufacturing of GMP-compliant anti-EGFR targeted nanocarriers: production of doxorubicin-loaded anti-EGFR-immunoliposomes for a first-in-man clinical trialAndreas Wicki, Reto Ritschard, Uli Loesch, et al.Journal of Gastrointestinal Cancer|May 28, 2026
Trends in Pancreatic Cancer Incidence, Mortality and Net Survival: A Population-Based Analysis in Zurich (Switzerland), 1981-2021Linda Vinci, Miriam Wanner, Andreas Wicki, et al.Scientific Reports|October 10, 2025
Towards scalable and cross-lingual specialist language models for oncologyMorteza Rohanian, Tarun Mehra, Nicola Miglino, et al.Swiss Medical Weekly|October 4, 2002
Determination of the donor:host blood cell ratio after haematological stem cell transplant by means of semiquantitative detection of short tandem repeat polymorphismsAndreas Wicki, Naseem Malik, Alois Gratwohl, et al.Journal of Drug Targeting|April 24, 2012
Immunoliposomal delivery of doxorubicin can overcome multidrug resistance mechanisms in EGFR-overexpressing tumor cellsChristoph Mamot, Reto Ritschard, Andreas Wicki, et al.Pageof 9